HL

Hans Loibner

AA Apeiron Biologics Ag: 13 patents #1 of 32Top 4%
AT AT&T: 3 patents #5,550 of 18,772Top 30%
SA Sandoz Ag: 3 patents #174 of 1,103Top 20%
GG Greenovation Biotech Gmbh: 2 patents #4 of 28Top 15%
UN Unknown: 2 patents #12,644 of 83,584Top 20%
MI Medizinische Universität Innsbruck: 1 patents #7 of 35Top 20%
📍 Wien, AT: #32 of 3,624 inventorsTop 1%
Overall (All Time): #112,115 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 1–25 of 32 patents

Patent #TitleCo-InventorsDate
11597775 Preparations and methods for treating a GD2 positive cancer Oliver Mutschlechner, Ruth Ladenstein, Isabel Klier 2023-03-07
11492412 Preparations and methods for treating a GD2 positive cancer Oliver Mutschlechner, Ruth Ladenstein, Isabel Klier 2022-11-08
11447565 Method for treating a GD2 positive cancer Manfred Schuster, Evelyne Janzek-Hawlat, Susanne Wiederkum, Bernhard Peball, Stefan Stranner +4 more 2022-09-20
11079398 Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples Marko Poglitsch, Cornelia Schwager, Manfred Schuster 2021-08-03
10995147 Preparations and methods for treating a GD2 positive cancer Oliver Mutschlechner, Ruth Ladenstein, Isabel Klier 2021-05-04
10716833 Method for producing ACE2 polypeptide Manfred Schuster, Evelyne Janzek-Hawlat, Bernhard Peball, Stefan Stranner, Bettina Wagner +1 more 2020-07-21
10472341 Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases Monika Ermann, Guenther Lametschwandtner, Patricia Amouzegh, Russell Stuart Craft, Thomas Hanke +7 more 2019-11-12
10294305 Method for treating a GD2 positive cancer Oliver Mutschlechner, Ruth Ladenstein, Isabel Klier 2019-05-21
9839668 Compositions and methods for the treatment of diseases related to the renin-angiotensin-system Marko Poglitsch, Cornelia Schwager 2017-12-12
9840566 Preparations and methods for treating a GD2 positive cancer Oliver Mutschlechner, Ruth Ladenstein, Isabel Klier 2017-12-12
9777068 Method for treating a GD2 positive cancer Manfred Schuster, Evelyne Janzek-Hawlat, Susanne Wiederkum, Bernhard Peball, Stefan Stranner +4 more 2017-10-03
9757433 Modified ACE2 polypeptides Bernhard Peball, Manfred Schuster, Stefan Stranner 2017-09-12
9684004 Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples Marko Poglitsch, Cornelia Schwager, Manfred Schuster 2017-06-20
9561263 Treatment of inflammatory illnesses with ACE2 Manfred Schuster 2017-02-07
9186373 SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer Gunther Lametschwandtner, Manfred Schuster, Isabella Haslinger, Sandra Seidl 2015-11-17
8946162 Treatment of tumors Evelyne Janzek-Hawlat, Manfred Schuster, Bernhard Peball 2015-02-03
8809288 Method for increasing immunoreactivity Gottfried Baier, Manfred Schuster, Gunther Lametschwandtner, Dominik Wolf 2014-08-19
8586319 Recombinant ACE2 polypeptide dimer Manfred Schuster, Evelyne Janzek-Hawlat, Bernhard Peball, Stefan Stranner, Bettina Wagner +1 more 2013-11-19
8444974 Use of antibodies for the vaccination against cancer Helmut Eckert 2013-05-21
8323650 Method of treating lewis Y-expressing tumors Manfred Schuster, Gottfried Himmler, Guenter Waxenecker, Geert Mudde, Manuela Loidl +1 more 2012-12-04
8241864 Method for determining ACE2 activity Manfred Schuster, Evelyne Janzek-Hawlat 2012-08-14
8153135 Polysaccharide-polypeptide conjugate Helmut Eckert 2012-04-10
8062625 Cancer immunotherapy predictive parameters 2011-11-22
8034338 Immunogenic recombinant antibody Gottfried Himmler, Gunter Waxenecker, Manfred Schuster, Thomas Putz 2011-10-11
7759464 N-glycosylated antibody Manfred Schuster, Gottfried Himmler, Gunter Waxenecker, Geert Mudde, Manuela Loidl +1 more 2010-07-20